Netherlands-based Kiadis Pharma NV has appointed Andrew Sandler, a former executive at Medivation Inc (now Pfizer), as its chief medical officer. Dr Sandler will oversee the commercialisation strategy for the company’s cell therapy products aimed at making bone marrow transplantations safer. In addition to working at Medivation, Dr Sandler held senior roles at Dendreon Pharmaceuticals Inc and Spectrum Pharmaceuticals Inc.
Dr Sandler obtained his MD from the Mount Sinai School of Medicine in New York City, US and completed a fellowship in medical oncology at the University of California San Francisco.
Kiadis announced the appointment on 29 September 2017.
Copyright 2017 Evernow Publishing Ltd